Tyrosine kinase inhibitor treatments in patients with metastatic thyroid carcinomas: a retrospective study of the TUTHYREF network.

Massicotte, Marie-Hélène

Tyrosine kinase inhibitor treatments in patients with metastatic thyroid carcinomas: a retrospective study of the TUTHYREF network. [electronic resource] - European journal of endocrinology Apr 2014 - 575-82 p. digital

Publication Type: Journal Article; Observational Study

1479-683X

10.1530/EJE-13-0825 doi


Adenocarcinoma--drug therapy
Adenocarcinoma, Follicular--drug therapy
Adenoma, Oxyphilic
Adult
Aged
Antineoplastic Agents--therapeutic use
Bone Neoplasms--drug therapy
Carcinoma--drug therapy
Carcinoma, Neuroendocrine
Carcinoma, Papillary
Disease-Free Survival
Female
Humans
Indoles--therapeutic use
Liver Neoplasms--drug therapy
Lung Neoplasms--drug therapy
Lymphatic Metastasis
Male
Middle Aged
Niacinamide--analogs & derivatives
Phenylurea Compounds--therapeutic use
Piperidines--therapeutic use
Pleural Neoplasms--drug therapy
Protein-Tyrosine Kinases--antagonists & inhibitors
Pyrroles--therapeutic use
Quinazolines--therapeutic use
Retrospective Studies
Sorafenib
Sunitinib
Thyroid Cancer, Papillary
Thyroid Neoplasms--drug therapy
Treatment Outcome